Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Download PDF

Spectrum of central nervous system infections in a tertiary health care centre in Cameroon

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery volume 58, Article number: 18 (2022) Cite this article

Abstract

Background

Central nervous system (CNS) infections are serious and debilitating diseases with significant mortality, and high prevalence in the context of human immunodeficiency virus (HIV) pandemic in Africa. However, their diagnosis remains challenging due to outdated technical platform. We aimed to determine the frequency of CNS infection and to describe the epidemiological, clinical and outcome of this at the Douala General Hospital (DGH), Cameroon. To carry out this study, we collected the medical records of patients hospitalized for CNS infections in the internal medicine department of DGH from January 2015 to December 2019.

Results

Among 8430 files reviewed, 336 cases of CNS infection were identified giving a frequency of CNS infection of 3.99% among which 204 files were included in the study (54.4% were male). HIV infection was found in 147 patients (72.1%) with 38.1% (n = 56) of them on regular follow-up. The most common clinical signs were fever (84.8%), headache (68.6%), meningeal syndrome (38.7%), and seizures (36.3%). Cerebral toxoplasmosis (24.5%), cryptococcal meningitis (21.1%), and acute bacterial meningitis (8.3%) were leading aetiologies. Of the 143 CSF samples, 70.6% (n = 101) were sterile. The in-hospital mortality rate was 23.5% with CNS infection of unknown cause (22.1%) be independently associated to this [OR = 2.24; 95% CI 1.04–4.80, p = 0.039].

Conclusion

Clinical presentations of CNS infections are same with classical data. HIV-related opportunistic infections are the main aetiologies. About one over four patients with CNS died. Two thirds of CSF are sterile using basic laboratory assessment giving a need to identify simple tests to increase sensibility and specificity of diagnostic tools in our setting.

Background

Central nervous system (CNS) infections are potentially life-threatening conditions that constitute a diagnostic and therapeutic emergency [1,2,3,4,5]. It is a group of neurological conditions with varying symptoms depending on the type of infection, the pathogen involved and the site in which they occur [4, 6]. These infections are caused by microorganisms (viruses, bacteria, fungi, protozoa); macro-organisms and microparticles (prions) [3, 6,7,8]. The causative organisms vary depending on their location in the CNS, geographic exposure, vaccination status, age, surgical procedures and immune status [2, 8]. Knowledge of the most common aetiologies is important for the appropriate choice of antimicrobial therapy, which must be instituted promptly to reduce morbidity and mortality and prevent long-term neurological sequelae [2, 3]. CNS infections are relatively rare in developed countries but remain a public health problem in developing countries [1, 9, 10].

The global incidence of CNS infections between 1990 and 2016 is estimated at 389/100,000 [12]. In Africa, pooled data on CNS infections are scarce. Meningitis epidemics have, however, been declared in the countries of the Sub-Saharan meningitis belt [13,14,15,16]. In Nigeria, 393,614 cases of meningitis were reported between 1991 and 2011 by the World Health Organization (WHO) [17]. Immunosuppression is frequently associated to CNS infections. Thus, patients infected with the Human Immunodeficiency Virus (HIV) will be more exposed to these infections [18,19,20]. Between 2006 and 2016, 102 cases of cryptococcal meningitis were reported in Togo [20]. In Cameroon, between 2004 and 2009, cerebral toxoplasmosis (32%) and cryptococcal meningitis (25%) were reported as commonest CNS infections in HIV immunocompromised patients [19]. However, Streptococcus pneumonia (46%) and Neisseria meningitis (30%) were the main aetiologies among 135 cases of meningitis reported in Cameroon [21].

Morbidity and mortality associated with CNS infections is higher compared to infections of other systems [5]. Despite remarkable progress in their prevention and management, CNS infections remain a major cause of death, particularly in developing countries and in immunocompromised patients [7]. Without treatment, the mortality from bacterial meningitis is close to 100%, while with adequate treatment the mortality is reduced to 4.2% [22]. The overall mortality from viral encephalitis is estimated between 3.8% and 7.4% with an incidence of 2.2/100,000 in adults and 6.3/100,000 at any age [23]. This study aims to provide data in a resource limited area for decision-making and improvement of the management of this public health concern.

Methods

A retrospective cohort study was conducted in the internal medicine department of the Douala General Hospital (DGH). Medical files were reviewed for patients aged 16 years and above, hospitalized between January 1, 2015 and December 31, 2019 for CNS infection diagnosed via neuroimaging (brain CT scan and MRI) with and without cerebrospinal fluid (CSF) analysis. All patients performed at least brain CT scan/MRI and/or CSF analysis. Each file stored in the archives was recorded in a register, as well as in a computer which contained the hospital reports of each patient. Incomplete files, especially without neuroimaging and/or CSF analysis results were excluded. Ethical approval was obtained from institutional ethics committee of the University of Douala (No. 2162CEI-UDo/01/2020/T).

The following data were collected from selected medical files: (1) sociodemographic data: age, gender, profession, marital status; (2) comorbidities: HIV, diabetes, hypertension, chronic kidney disease (CKD); (3) clinical data: neurological and extra-neurological signs; (4) paraclinical workups: neuroimaging (brain CT scan or MRI), CSF analysis when done, and other biological testing, such as CBC, CRP, blood culture; and (5) outcome: mean length of hospitalization and mortality.

The CSF analysis carried out by the laboratory of the DGH are classically: biochemistry (protein and glucose level), cell count (leucocytes and red blood cells), direct detection (Gram stain, India ink, and Ziehl–Neelsen stain), culture on blood or chocolate agar (bacteria), Lowenstein–Jensen medium (Mycobacterium tuberculosis), Sabouraud dextrose agar (fungi), soluble bacterial antigens, cryptococcal antigens, and Veneral disease research laboratory (VDRL)/Treponemal Pallidum Hemagglutination assay (TPHA). When requested, a real-time polymerase chain reaction (PCR) for Mycobacterium tuberculosis also called Xpert MTB/RIF Molecular Beacon Assay was performed at the laboratory of the Regional Delegation of Public Health of the Littoral. Hypoglycorachia was defined as a CSF glucose level less than half of the glycaemia; hyperproteinorachia was defined as a CSF protein level in the CSF greater than 0.45 g/L; and pleocytosis was considered as a white cell count > 5 cells/mm3.

Statistical analysis

The data collected was recorded in our database and was analysed using SPSS software version 23.0. Categorical variables were expressed as frequencies with percentages. Continuous variables were presented as mean ± standard deviation (SD). χ2 and Student tests were used to compare categorical and continuous variables, respectively. Multivariate analysis using logistic regression was performed to determine factors associated to death. Results were considered significant for a p-value < 0.05.

Results

Out of the 8430 files reviewed, 336 cases of CNS infection were identified, of which 204 met the inclusion criteria. From 2015 to 2019, the hospital-based frequency of CNS infections ranged from 2.2% to 2.6% (Fig. 1).

Fig. 1
figure 1

Trends of CNS infection from 2015 to 2019

Full size image

The mean age of the patients was 42.6 ± 13.79 years (16–84 years). The most common age groups were 30–40 years (29.9%) and 40–50 years (28.4%). Male patients accounted for 54.4% of cases. HIV infection was found in 147 cases (72.1%) with 61.9% of them not on regular follow-up with highly active antiretroviral therapy (HAART) (Table 1).

Table 1 Risk factors and comorbidities
Full size table

The most common neurological signs were headache (68.6%), impaired consciousness (44.1%), signs of meningeal irritation (38.7%), and epileptic seizures (36.3%), while altered general state (93.1%), fever (84.8%) and vomiting (35.8%) were main extra-neurological signs (Table 2).

Table 2 Clinical manifestations in patients with CNS infections
Full size table

Neuroimaging was performed in 177 patients (brain CT scan = 131; brain MRI = 46). Results were abnormal in 117 cases with brain mass representing the commonest lesion reported. These abnormalities were found in 65.6% and 67.4% of brain CT scan and brain MRI, respectively. Lumbar puncture with CSF analysis was performed in 143 patients. Results showed hypoglycorachia (n = 67; 46.6%), hyperproteinorachia (n = 103; 77.4%), and pleiocytosis (n = 42; 29.4%). CSF microbiological analysis was positive for Cryptococcus neoformans (n = 38), Neisseria meningitidis (n = 1), Streptococcus pneumoniae (n = 1) and Pseudomonas aeruginosa (n = 1). No acid-fast bacilli were detected through the Ziehl–Neelsen stain. PCR was positive for Mycobacterium tuberculosis in three cases. Among the patients with HIV, the mean CD4 count (in 94 patients) was less than 350 cells/mm3 in 92.3% of cases. The most frequent aetiologies were cerebral toxoplasmosis (24.5%) and cryptococcal meningitis (21.1%), while unknown aetiology was founded in 34.8% of cases (Fig. 2).

Fig. 2
figure 2

Aetiologies of CNS infections

Full size image

The mean length of hospitalization was 9.5 ± 7.1 days with an in-hospital mortality was 23.5%. In the univariate analysis, factors associated with in-hospital mortality were: age groups of 30–40 (p = 0.012), 40–50 (p = 0.011) and CNS of unknown aetiology (p = 0.006). After multivariate analysis, only CNS infection of unknown aetiology was independently associated to the in-hospital mortality (OR = 2.24, 95% CI 1.04–4.8), p = 0.039) (Table 3).

Table 3 Predictive factors of mortality
Full size table

Discussion

This study reviewed cases of CNS infections in a referral hospital in Cameroon and aimed to determine his frequency and to describe their characteristics. There was a slight increase in the number of cases reported from 2015 to 2019. HIV was the main comorbidity associated to CNS infections. The main aetiologies were HIV related opportunistic CNS infections. The in-hospital mortality was significant.

In Sub-Saharan Africa (SSA), CNS infections are frequent causes of admission in neurology [24]. The overall intra-hospital prevalence of CNS infections in this study was underestimated. A recent study done in Cameroon including patients from outpatient department and hospitalization in two referral hospitals reported a prevalence of 11.3% in 2018 in Cameroon [11]. The flow of patients hospitalized for CNS infection does not reflect the reality.

Young adults represented the main age group. Several studies in Africa reported similar data [19, 25,26,27]. In Europe, Erdem et al. found a mean higher than our findings [28]. This gap could be explained by the difference in demographical characteristics of African and European populations. In addition, the most frequent age groups in this study are similar to the HIV most affected age groups in the Cameroonian population (Cameroon population-based HIV impact assessment, 2017). The male predominance found in this study was consistent with other studies [26, 29,30,31]. Genetic and hormonal difference may contribute to this gender difference. Oestrogens was described to play a protective role against infections by reducing the inflammatory response [32]. Close to three quarters of patients were PLWH. Similar results were reported in Ivory Coast and Mali [27, 33].

Clinical manifestations are often similar to those of classical data [4]. In this study, the neurological signs were mainly: headache, impaired consciousness, meningeal syndrome, and seizures. Diarra et al. found meningeal syndrome in 34.5% of cases [27]. Meningeal syndrome is a clinical expression of the inflammatory reaction produced when the meninges are invaded by a pathogen. Thus, a frank meningeal syndrome would reflect a significant inflammatory response of the CNS. The population in this study is characterized by a high frequency of HIV infection low immunity (CD4 cells less than 350/mm3). This could explain the lower inflammatory response, hence the low frequency of patients with meningeal syndrome [34].

The leading aetiologies were cerebral toxoplasmosis (24.5%), cryptococcal meningitis (21.1%), and acute bacterial meningitis (5.9%). These findings are consistent with a study done by Luma et al. in 2013, which found cerebral toxoplasmosis (32.3%) and cryptococcal meningitis (25%) as the commonest aetiologies [19]. Given the endemic context of HIV and the high frequency of people living with HIV (PLWH) in our context, opportunistic infections such as cerebral toxoplasmosis and cryptococcal meningitis remain very frequent [35]. The occurrence of opportunistic infections is favoured by the low rate of patients with HIV under regular HAART in this population. In more than one-third of cases, the aetiology remains undetermined compared to 8.8% of cases reported in Europe [28]. This diagnostic gap reflects the difficulty encountered in resource-limited settings [3]. These difficulties are accentuated by the fact that more than a quarter of these patients are referred from primary health centres, where patients receive empirical antibiotics without any microbiological evidence. More efficient diagnostic tools may contribute to improve the identification of pathogens.

In 2013, Luma et al. reported a mortality of 49% in PLWH which is more than two time higher than our finding [19]. Several studies have reported mortality rates greater than 10% [21, 26, 27, 36]. Cerebral toxoplasmosis represented the lowest case fatality rate in this series. In multivariate analysis, there was a statistically significant association between the occurrence of death and the undetermined aetiologies (adjusted OR = 2.24; p = 0.039). This could be explained by the fact that without knowing of the causes, specific treatment cannot be instituted, thereby increasing the risk of death [1].

This study places the foundations for epidemiological data on CNS infections in Cameroon. However, the retrospective design of this study leads to data collection challenges with up to 132 incomplete medical files excluded. This could have impacted the reliability of results. In addition, this study was conducted in one hospital, and therefore, data cannot be generalized in the entire community.

Conclusions

Clinical presentations of CNS infections are same with classical data. HIV-related opportunistic infections are the main aetiologies. Mortality remains high in our context. Two over third CSF are sterile using basic laboratory assessment giving a need to implement simple tests to increase sensibility and specificity of diagnostic tools in our setting.

Availability of data and materials

Data can be made available upon reasonable request.

Abbreviations

CNS:

Central nervous system

HIV:

Human immune-deficiency virus

DGH:

Douala general hospital

CSF:

Cerebrospinal fluid

WHO:

World Health Organization

CT:

Computed tomography

MRI:

Magnetic resonance imaging

CKD:

Chronic kidney disease

CBC:

Complete blood count

CRP:

C-reactive protein

VDRL:

Veneral disease research laboratory

TPHA:

Treponemal Pallidum Hemagglutination assay

PCR:

Polymerase chain reaction

MTB/RIF:

Mycobacterium tuberculosis DNA and resistance to rifampicin

SD:

Standard deviation

HAART:

Highly active antiretroviral therapy

PLWH:

People living with human immune-deficiency virus

References

  1. Sarrazin J, Bonneville F, Martin-blondel G. Infections cérébrales. J Radiol Diagnostique Interv. 2019;93(6):503–20. https://doi.org/10.1016/j.jradio.2012.03.003.

    Article  Google Scholar 

  2. Riddell J, Shuman EK. Epidemiology of central nervous system infection. Neuroimaging Clin N Am. 2012;22(4):543–56.

    Article  Google Scholar 

  3. Giovane RA. Central nervous system infections. Prim Care Clin Off Pract. 2018. https://doi.org/10.1016/j.pop.2018.05.007.

    Article  Google Scholar 

  4. Ahmed MM. Clinical presentation and outcome of bacterial Meningitis in University Hospital. Adv Infect Dis. 2014;4:124–31.

    Google Scholar 

  5. Parikh V, Tucci V, Galwankar S. Infections of the nervous system. Int J Crit Illn Inj Sci. 2012;2(2):82.

    Article  Google Scholar 

  6. John CC, Carabin H, Montano SM, Bangirana P, Zunt JR, Peterson PK. Global research priorities for infections that affect the nervous system. Nature. 2015;527(7578):S178–86. https://doi.org/10.1038/nature16033.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Shih RY, Koeller KK. Bacterial, fungal, and parasitic infections of the central nervous system: radiologic-pathologic correlation and historical perspectives. Radiographics. 2015;35(4):1141–69. https://doi.org/10.1148/rg.2015140317.

    Article  PubMed  Google Scholar 

  8. Giri A, Arjyal A, Koirala S, Karkey A, Dongol S, Thapa SD, Shilpakar O, Shrestha R, van Tan L, Thi Thuy Chinh BN, Krishna KCR, Pathak KR, Shakya M, Farrar J, Van Doorn HR, Basnyat B. Aetiologies of central nervous system infections in adults in Kathmandu, Nepal: a prospective hospital-based study. Sci Rep. 2013;3:2382. https://doi.org/10.1038/srep02382.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Asiedu-bekoe F, Acheampong GK. Epidemiological dynamics of a bacterial meningitis outbreak in two districts in Northern Ghana. Open Access Libr J. 2016;3:1–12. https://doi.org/10.4236/oalib.1102993.

    Article  Google Scholar 

  10. Zhao S, Lin Q, He D, Stone L. Meningitis epidemics shift in sub-Saharan belt. Int J Infect Dis. 2018;68:79–82. https://doi.org/10.1016/j.ijid.2018.01.020.

    Article  PubMed  Google Scholar 

  11. Mapoure NY, Doumbe J, Gams Massi D, Nyinyikua ST, Kuate TC, Luma NH. Epidémiologie clinique des affections neurologiques dans la ville de Douala. Rev Méd Pharm. 2018;8:738–50.

    Google Scholar 

  12. Robertson FC, Lepard JR, Mekary RA, Davis MC, Yunusa I, Gormley WB, Baticulon RE, Mahmud MR, Misra BK, Rattani A, Dewan MC, Park KB. Epidemiology of central nervous system infectious diseases: a meta-analysis and systematic review with implications for neurosurgeons worldwide. J Neurosurg. 2018;1:1–20. https://doi.org/10.3171/2017.10.JNS17359.

    Article  Google Scholar 

  13. Davis LE. Acute bacterial meningitis. Continuum (Minneapolis, Minn). 2018;24(5):1264–83. https://doi.org/10.1212/con.0000000000000660.

    Article  Google Scholar 

  14. Hulten KG. Viral meningitis in the UK: time to speed up Risk factors in septic revisions following total hip arthroplasty. Lancet Infect Dis. 2018;18(9):930–1. https://doi.org/10.1016/S1473-3099(18)30287-1.

    Article  Google Scholar 

  15. Paradowska-Stankiewicz I, Piotrowska A, Polsce WW. Epidemiological chronicle / kronika epidemiologiczna meningitis and encephalitis in Poland In 2015 Zapalenia Opon Mózgowo-Rdzeniowych I Zapalenia Mózgu. Przegl Epidemiol. 2017;71(4):493–500.

    PubMed  Google Scholar 

  16. Chong H, Tan C. Epidemiology of central nervous system infections in Asia, recent trends. Neurol Asia. 2005;10:7–11.

    Google Scholar 

  17. Abdussalam AF, Qaffas Y. Spatiotemporal patterns and social risk factors of meningitis in Nigeria. Open Access Libr J. 2016;3:1–14.

    Google Scholar 

  18. Luma HN, Tchaleu BCN, Mapoure YN, Temfack E, Doualla MS, Halle MP, Joko HA, Koulla-Shiro S. Toxoplasma encephalitis in HIV/AIDS patients admitted to the Douala general hospital between 2004 and 2009: a cross sectional study. BMC Res Notes. 2013;6:146. https://doi.org/10.1186/1756-0500-6-146.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Luma HN, Tchaleu BC, Temfack E, Doualla MS, Ndenga DP, Mapoure YN, Njamnshi AK, Djientcheu VD. HIV-associated central nervous system disease in patients admitted at the Douala general hospital between 2004 and 2009: a retrospective study. AIDS Res Treat. 2013;2013: 709810. https://doi.org/10.1155/2013/709810.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Wateba IM, Balaka A, Bawe AL, Kotosso A. Cryptococcal meningitis of the HIV-infected Person in Lomé: about 102 cases over 10 years. World J AIDS. 2017;7:217–22.

    Article  Google Scholar 

  21. Mapoure YN, Luma HN, Gnonlonfoun D, Ossou-guiet PM, Biloa X, Doumbe JN, Mbatchou HBN, Tchaleu BCN, Fonsah JY, Mouelle AS, Njamnshi AK. Spectrum of meningitis in adult at the Douala general hospital. World J Neurosci. 2014;4:144–51.

    Article  Google Scholar 

  22. Li C, Feng W, Lin A, Zheng G, Wang Y, Han Y, Zhong J, Bi J, Luo Q, Zhao F. Clinical characteristics and etiology of bacterial meningitis in Chinese children > 28 days of age, January 2014–December 2016: a multicenter retrospective study. Int J Infect Dis. 2018;74:47–53. https://doi.org/10.1016/j.ijid.2018.06.023.

    Article  PubMed  Google Scholar 

  23. Ben F, Abukhattab M, Ghazouani H, Khalil O, Gohar A, Al H, et al. International Journal of Infectious Diseases Epidemiology and clinical outcomes of viral central nervous system infections. Int J Infect Dis. 2018;73:85–90. https://doi.org/10.1016/j.ijid.2018.06.008.

    Article  Google Scholar 

  24. Andriantseheno LM, Andrianasy TF. Hospital based study on neurological disorders in Madagascar. Data from the northwestern part of the island. AJNS, 1997;16(2).

  25. Rachid MG. Infections du système nerveux au service de neurologie du centre hospitalier universitaire Mohammed VI de Marrakech [Thèse de médecine]. Marrakech: Université CADDI AYYAD; No. 74: 2014, p. 140.

  26. Ouattara B, Eholie SP, Adoubryn KD, Kra O, Tia H, Kouadio-Yapo C, Edo V, Ouhon J. Étude retrospective des méningites bactériennes et à cryptocoques chez des sujets adultes infectés par le VIH à Abidjan (Côte d’Ivoire). J Mycol Med. 2007;17:82–6. https://doi.org/10.1016/j.mycmed.2007.02.003.

    Article  Google Scholar 

  27. Diarra B. Atteintes cérébroméningées dans le service des Maladies Infectieuses et Tropicales du CHU du Point G [Thèse de médecine]. Point G: Université de Bamako; 2012;1–60.

  28. Erdem H, Inan A, Guven E, Hargreaves S, Larsen L, Shehata G, et al. The burden and epidemiology of community-acquired central nervous system infections: a multinational study. Eur J Clin Microbiol Infect Dis. 2017;10:36.

    Google Scholar 

  29. Akhvlediani T, Bautista CT, Shakarishvili R, Tsertsvadze T, Imnadze P, Tatishvili N, et al. Etiologic agents of central nervous system infections among febrile hospitalized patients in the Country of Georgia. PLoS ONE. 2014;9(11):5–11.

    Article  Google Scholar 

  30. Ho Dang Trung N, Le Thi Phuong T, Wolbers M, et al. Aetiologies of central nervous system infection in Viet Nam: a prospective provincial hospital-based descriptive surveillance study. PLoS ONE. 2012;7(5):e37825. https://doi.org/10.1371/journal.pone.0037825.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Godjedo TP, Paraiso MN, Agbankpe AJ, Dougnon TV, Degbey C, Ahoyo A, et al. Case-by-case surveillance for bacterial meningitis in benin: data analysis 2016 to 2018. Open J Epidemiol. 2020;1–14.

  32. Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, Möller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019;13:1–12.

    Article  Google Scholar 

  33. Sarrazin JL, Bonneville F, Martin-Blondel G. Brain infections. Diagn Interv Imaging. 2012;93(6):473–90. https://doi.org/10.1016/j.diii.2012.04.020.

    Article  PubMed  Google Scholar 

  34. Forrester JV, Mcmenamin PG, Dando SJ. CNS infection and immune privilege. Nat Rev Neurosci. 2018;19:655–71. https://doi.org/10.1038/s41583-018-0070-8.

    Article  CAS  PubMed  Google Scholar 

  35. Bowen LN, Smith B, Reich D, Quezado M, Nath A. HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nat Rev Neurol. 2016;12(11):662–74. https://doi.org/10.1038/nrneurol.2016.149.

    Article  CAS  PubMed  Google Scholar 

  36. Essayagh T, Essayagh M, Essayagh S. Vital prognostic factors of bacterial meningitis in Morocco: a 12-year study. J Clin Exp Pathol. 2017;7(4):318. https://doi.org/10.4172/2332-0877.1000318.

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to Ruth Ebongue, in charge of the medical records of the Internal Medicine department of the Douala General Hospital, for her complete collaboration.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Faculty of Health Sciences, University of Buea, Buea, Cameroon

    Daniel Gams Massi & Seraphine Mojoko Eko

  2. Internal Medicine Department, Douala General Hospital, PO Box: 4856, Douala, Cameroon

    Daniel Gams Massi, Caroline Kenmegne, Salomon Mbahe, Hugo Bertrand Mbatchou Ngahane & Njankouo Yacouba Mapoure

  3. Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon

    Marcel Roger Rodrigue Mintyene Mintyene, Annick Mélanie Magnerou, Hugo Bertrand Mbatchou Ngahane & Njankouo Yacouba Mapoure

  4. Internal Medicine Department, Douala Gyneco-Obstetric and Paediatric Hospital, Douala, Cameroon

    Annick Mélanie Magnerou

  5. Department of Neurology, Marien Ngouabi University, Brazzaville, Republic of Congo

    Prince Eliot Sounga Bandzouzi

Authors
  1. Daniel Gams Massi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcel Roger Rodrigue Mintyene Mintyene
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Annick Mélanie Magnerou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seraphine Mojoko Eko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Caroline Kenmegne
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Salomon Mbahe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Prince Eliot Sounga Bandzouzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hugo Bertrand Mbatchou Ngahane
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Njankouo Yacouba Mapoure
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Research project: conceptualization, DGM, MRRMM and NYM; methodology, DGM, MRRMM and NYM; software, DGM, MRRMM; validation, HBMN and NYM; investigation, DGM, MRRMM; resources, KC and MS; data curation, DGM and AMM; writing—original draft preparation, DGM and MRRMM; writing—review and editing, DGM, AMM, ESM, PESB; supervision, NYM; project administration, DGM, HBMN and NYM. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Daniel Gams Massi.

Ethics declarations

Ethics approval and consent to participate

Ethical approval was obtained from institutional ethics committee of the University of Douala (No. 2162CEI-UDo/01/2020/T) of the 29th January, 2020. In this study, we reviewed the anonymized medical records of patients.

Consent for publication

Not applicable.

Competing interests

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gams Massi, D., Mintyene Mintyene, M.R.R., Magnerou, A.M. et al. Spectrum of central nervous system infections in a tertiary health care centre in Cameroon. Egypt J Neurol Psychiatry Neurosurg 58, 18 (2022). https://doi.org/10.1186/s41983-022-00454-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s41983-022-00454-0

Keywords

  • CNS infection
  • HIV
  • Cerebral toxoplasmosis
  • Douala
  • Cameroon